These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31584959)

  • 21. Economic Costs and Benefits of a Community-Based Lymphedema Management Program for Lymphatic Filariasis in Odisha State, India.
    Stillwaggon E; Sawers L; Rout J; Addiss D; Fox L
    Am J Trop Med Hyg; 2016 Oct; 95(4):877-884. PubMed ID: 27573626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue tonometry: a useful tool for assessing filarial lymphedema.
    Kar SK; Kar PK; Mania J
    Lymphology; 1992 Jun; 25(2):55-61. PubMed ID: 1405748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experiences of a Community-Based Lymphedema Management Program for Lymphatic Filariasis in Odisha State, India: An Analysis of Focus Group Discussions with Patients, Families, Community Members and Program Volunteers.
    Cassidy T; Worrell CM; Little K; Prakash A; Patra I; Rout J; Fox LM
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004424. PubMed ID: 26849126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Digital Volumetric Measurements Based on 3D Scans of the Lower Limb: A Valid and Reproducible Method for Evaluation in Lymphedema Therapy.
    Schiltz D; Diesch ST; Kiermeier N; Eibl D; Felmerer G; Schreml S; Biermann N; Prantl L; Taeger CD
    Ann Vasc Surg; 2024 Aug; 105():209-217. PubMed ID: 38579911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reassessment of areas with persistent Lymphatic Filariasis nine years after cessation of mass drug administration in Sri Lanka.
    Rao RU; Samarasekera SD; Nagodavithana KC; Dassanayaka TDM; Punchihewa MW; Ranasinghe USB; Weil GJ
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006066. PubMed ID: 29084213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Benefits of Supervised Home Care of the Morbidity Management and Disability Prevention Under National Filariasis Elimination Programme.
    De Britto L; Kamaraj P; Vijayalakshmi G; Das LK; Krishnakumari A; Anbusivam S; Supriya VK; Yuvaraj J
    Lymphat Res Biol; 2020 Dec; 18(6):517-525. PubMed ID: 32584670
    [No Abstract]   [Full Text] [Related]  

  • 27. Application of the Lower Extremity Functional Scale and Its Correlation with Lymphedema Health-Related Quality of Life on Lower Limb Filarial Lymphedema Patients.
    Lourduraj B; Barnawal SP; Pattabi K; Gnanasekaran V; Sadhasivam A; Vinod KS; Sharma D; Jayaram Y
    Lymphat Res Biol; 2020 Jun; 18(3):254-260. PubMed ID: 31532703
    [No Abstract]   [Full Text] [Related]  

  • 28. Extensive myiasis of the leg in a patient with filarial lymphedema: implications for morbidity care in filariasis elimination program.
    Kuttiatt VS; Venkatesan S; Srinivasan V; De Britto L; Rahi M; Kumar A
    J Vector Borne Dis; 2021; 58(4):391-393. PubMed ID: 35381831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful multi-modal treatment of grade IV lymphedema in lymphatic filariasis: A case study.
    Sivaprakasam R; Anuradha R; Bethunaickan R; Manokaran G
    Lymphology; 2018; 51(2):89-92. PubMed ID: 30253461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. It is possible: availability of lymphedema case management in each health facility in Togo. Program description, evaluation, and lessons learned.
    Mathieu E; Dorkenoo AM; Datagni M; Cantey PT; Morgah K; Harvey K; Ziperstein J; Drexler N; Chapleau G; Sodahlon Y
    Am J Trop Med Hyg; 2013 Jul; 89(1):16-22. PubMed ID: 23690550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does the morbidity management and disability prevention (MMDP) clinic serve the filarial lymphedema (FLE) patients' preeminent expectation?
    De Britto RLJ; Vijayalakshmi G; Boopathi K; Kamaraj P; Supriya VK; Yuvaraj J
    Trop Biomed; 2020 Mar; 37(1):66-74. PubMed ID: 33612719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Far-Infrared Radiation Thermotherapy Improves Tissue Fibrosis in Chronic Extremity Lymphedema.
    Li K; Zhang Z; Liu NF; Sadigh P; Evans VJ; Zhou H; Gao W; Zhang YX
    Lymphat Res Biol; 2018 Jun; 16(3):248-257. PubMed ID: 28961078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment-seeking behavior and treatment practices of lymphatic filariasis patients with lymphoedema in the Colombo district, Sri Lanka.
    Wijesinghe RS; Wickremasinghe AR; Ekanayake S; Perera MS
    Asia Pac J Public Health; 2008; 20(2):129-38. PubMed ID: 19124306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predominant CD8+ infiltrate in limb biopsies of individuals with filarial lymphedema and elephantiasis.
    Freedman DO; Horn TD; Maia e Silva CM; Braga C; Maciel A
    Am J Trop Med Hyg; 1995 Dec; 53(6):633-8. PubMed ID: 8561266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Giant Scrotal Hydrocele and Bilateral Leg Lymphedema as Clinical Manifestation of Chronic Lymphatic Filariasis.
    Wijaya I; Pangestu W
    Acta Med Indones; 2016 Jul; 48(3):239-241. PubMed ID: 27840360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormalities of the leg lymphatics are not specific for bancroftian filariasis.
    Marchetti F; Piessens WF; Medeiros Z; Dreyer G
    Trans R Soc Trop Med Hyg; 1998; 92(6):650-2. PubMed ID: 10326111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Managing Lymphedema Induced by Lymphatic Filariasis: Implementing and Improving Care at the Individual and Programmatic Levels.
    Mackenzie CD; Kapa DR; Krishnasastry S; Douglass J; Hoerauf A; Ottesen EA
    Am J Trop Med Hyg; 2024 Oct; 111(4_Suppl):3-21. PubMed ID: 39084208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of domiciliary limb hygiene alone on lymphoedema volume and locomotor function in filarial lymphoedema patients in Puducherry, India.
    Das LK; Harichandrakumar KT; Vijayalakshmi G; De Britto LJ
    J Commun Dis; 2013; 45(1-2):17-23. PubMed ID: 25141550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A surveillance system for lymphatic filariasis after its elimination in Sri Lanka.
    Rahman MA; Yahathugoda TC; Tojo B; Premaratne P; Nagaoka F; Takagi H; Kannathasan S; Murugananthan A; Weerasooriya MV; Itoh M
    Parasitol Int; 2019 Feb; 68(1):73-78. PubMed ID: 30308253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive Assessment of a Hotspot with Persistent Bancroftian Filariasis in Coastal Sri Lanka.
    Rao RU; Samarasekera SD; Nagodavithana KC; Goss CW; Punchihewa MW; Dassanayaka TDM; Ranasinghe USB; Mendis D; Weil GJ
    Am J Trop Med Hyg; 2018 Sep; 99(3):735-742. PubMed ID: 30014812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.